Potential Therapeutic Role of Phosphodiesterase Type 5 Inhibition in Hypertension and Chronic Kidney Disease

Implications of Proteinuria: CKD Progression and Cardiovascular Outcomes

(2011) Mark J. Sarnak et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

(2011) Johannes-Peter Stasch et al.   CIRCULATION

Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease

(2011) T.-M. Lu et al.   Clinical Journal of the American Society of Nephrology

Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy

(2011) D. E. Kohan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction

(2010) Lennart G. Bongartz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats

(2010) Yoshihiro Kuno et al.   BRITISH JOURNAL OF PHARMACOLOGY

Is oxidative stress a therapeutic target in cardiovascular disease?

(2010) Thomas Münzel et al.   EUROPEAN HEART JOURNAL

Arterial stiffness in chronic kidney disease: causes and consequences

(2010) C. D. Chue et al.   HEART

Clinical Potential of Combined Organic Nitrate and Phosphodiesterase Type 5 Inhibitor in Treatment-Resistant Hypertension

(2010) James J. Oliver et al.   HYPERTENSION

Arterial functions: how to interpret the complex physiology

(2010) G. M. London et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Sildenafil attenuates renal ischemia reperfusion injury by decreasing leukocyte infiltration

(2009) Ozgur Oruc et al.   ACTA HISTOCHEMICA

Time-dependent interactions of the hypotensive effects of sildenafil citrate and sublingual glyceryl trinitrate

(2009) James J. Oliver et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Blood Pressure Lowering Effects of a New Long-Acting Inhibitor of Phosphodiesterase 5 in Patients With Mild to Moderate Hypertension

(2009) Robert Wolk et al.   HYPERTENSION

Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria

(2009) R. R. Wenzel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms

(2009) Ben Caplin et al.   KIDNEY INTERNATIONAL

The Role of Oxidative Stress in Chronic Kidney Disease

(2009) Ziad A. Massy et al.   SEMINARS IN DIALYSIS

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease

(2008) Pantelis A. Sarafidis et al.   AMERICAN JOURNAL OF MEDICINE

Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats

(2008) Kyung-Hwan Jeong et al.   AMERICAN JOURNAL OF NEPHROLOGY

Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity

(2008) Kang Wook Lee et al.   TOXICOLOGY

NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy

(2006) Philipp Kalk et al.   BRITISH JOURNAL OF PHARMACOLOGY